Brief: Senzime Outlicenses Exspiron In Chinese Market
June 19 (Reuters) - Senzime AB (publ) SEZI.ST :
* SENZIME OUTLICENSES EXSPIRON IN THE CHINESE MARKET
* ROYALTY INCOME TO SENZIME IS ESTIMATED TO EXCEED SEK 50
MILLION
DURING CONTRACT PERIOD
* AGREEMENT GRANTS CORESPIRON UP TO 10 YEARS OF
MANUFACTURING AND
SALES RIGHTS FOR SENZIME'S EXSPIRON SYSTEM IN CHINESE MARKET
Source text for Eikon: ID:nMFN3W0K3M
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Q3 Sales Up At SEK 30.1 Million
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract